Status
Acquired by US WorldMeds on August 13, 2010
Funding Received
$93 Million in 2 Rounds from 5 Investors
Headquarters:
South San Francisco, CA
Description:
Solstice Neurosciences is focused on the development, manufacturing, sales and marketing of specialty biopharmaceutical products.
Categories:
Biotechnology
Website:
http://www.solsticeneuro.com

Company Details

Update

Solstice Neurosciences is a specialty biopharmaceutical company focused on the development, manufacturing, sales and marketing of specialty biopharmaceutical products. Solstice’s first product named Myobloc® (rimabotulinumtoxinB) Injection in the U.S. and NeuroBloc® (Botulinum Toxin Type B) Injectable Solution in select overseas markets, represents the only botulinum toxin type B currently available to physicians and patients worldwide.

Investors (5)

Update

Offices/Locations (1)

Update
  • Office

    701 Gateway Boulevard

    Suite 250

    South San Francisco, CA 94080

    USA

Images (1)

Update
  • 649cd2ecee00a4707ca1472d41622cd0